Role for intracellular proteases in the processing and transport of class II HLA antigens
- PMID: 3287381
- PMCID: PMC280343
- DOI: 10.1073/pnas.85.11.3975
Role for intracellular proteases in the processing and transport of class II HLA antigens
Abstract
Human B-lymphoblastoid cell lines (B-LCL) incubated with the protease inhibitor leupeptin accumulate complexes of class II HLA antigens with a series of Mr 21,000-23,000 basic proteins termed leupeptin-induced proteins (LIP). The appearance of class II antigen-associated LIP coincides with the disappearance of class II antigen-associated invariant (I) chain. Glycopeptides generated by in vitro proteolysis of LIP and I chain using Staphylococcus aureus V8 protease are identical as determined by electrophoresis in sodium dodecyl sulfate. These results suggest that LIP is a proteolytic product derived from the I chain and are consistent with the view that further in vivo proteolysis of LIP by a leupeptin-sensitive enzyme normally facilitates its release from class II antigens. Incubation of B-LCL with monensin, which traps class II antigens and associated I chain in the Golgi apparatus, or chloroquine, which neutralizes intracellular acidic compartments and inhibits I-chain dissociation, blocks the leupeptin-induced appearance of LIP. Treatment of LIP with endoglycosidases F and H shows that both of its N-linked oligosaccharides are in the complex form, indicating that proteolysis of class II antigen-associated I chain to generate LIP occurs in a late-Golgi or post-Golgi compartment. The compartment in which these proteolytic events occur may be identical to the site in macrophages and B lymphocytes where foreign antigens are processed and interact with class II HLA molecules.
Similar articles
-
Structural analysis of proteolytic products of MHC class II-invariant chain complexes generated in vivo.J Immunol. 1993 Oct 15;151(8):4153-63. J Immunol. 1993. PMID: 8409392
-
HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes.J Immunol. 1996 Dec 15;157(12):5487-95. J Immunol. 1996. PMID: 8955198
-
Monensin prevents terminal glycosylation of the N- and O-linked oligosaccharides of the HLA-DR-associated invariant chain and inhibits its dissociation from the alpha-beta chain complex.Proc Natl Acad Sci U S A. 1984 Mar;81(5):1287-91. doi: 10.1073/pnas.81.5.1287. Proc Natl Acad Sci U S A. 1984. PMID: 6608726 Free PMC article.
-
Intracellular transport and peptide binding properties of HLA class II glycoproteins.Semin Immunol. 1990 Jul;2(4):273-80. Semin Immunol. 1990. PMID: 2104276 Review.
-
Biosynthesis and processing of class II histocompatibility antigens.Crit Rev Immunol. 1987;7(1):31-53. Crit Rev Immunol. 1987. PMID: 3545672 Review.
Cited by
-
DNA vaccines encoding Ii-PADRE generates potent PADRE-specific CD4+ T-cell immune responses and enhances vaccine potency.Mol Ther. 2007 Jun;15(6):1211-9. doi: 10.1038/sj.mt.6300121. Epub 2007 Mar 13. Mol Ther. 2007. PMID: 17356542 Free PMC article.
-
Transport and intracellular distribution of MHC class II molecules and associated invariant chain in normal and antigen-processing mutant cell lines.J Cell Biol. 1994 Jun;125(6):1225-37. doi: 10.1083/jcb.125.6.1225. J Cell Biol. 1994. PMID: 8207055 Free PMC article.
-
The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules.J Exp Med. 1994 Feb 1;179(2):681-94. doi: 10.1084/jem.179.2.681. J Exp Med. 1994. PMID: 8294875 Free PMC article.
-
Distinct binding sites on HLA-DR for invariant chain and staphylococcal enterotoxins.Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9657-61. doi: 10.1073/pnas.89.20.9657. Proc Natl Acad Sci U S A. 1992. PMID: 1409679 Free PMC article.
-
HLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes.Nat Immunol. 2007 Jan;8(1):92-100. doi: 10.1038/ni1414. Epub 2006 Dec 3. Nat Immunol. 2007. PMID: 17143275 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials